| Mepha Pharma AG - Deferasirox-Mepha 360 mg, Lactab | | 67678 | | 03 | | Deferasirox-Mepha 360 mg | | Lactab | | V03AC03 | | Deferasirox | | 24.08.2020 | | |
| | Composition | | deferasiroxum 360 mg, crospovidonum, cellulosum microcristallinum, poloxamerum 188, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 132, talcum, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Deferasirox | 360 mg |
| | BAG: Active Agent | Dose |
|---|
| Deferasirox | 360 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Poloxamer | 188 | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
